(Q40433289)

20 September 2017

1 reference

title

Tumor therapy by immune recruitment with bispecific antibodies (English)

1 reference

20 September 2017

Tumor Therapy by Immune Recruitment with Bispecific Antibodies (English)

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

30 May 2024

author name string

C. Renner

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7590826

30 May 2024

M. Pfreundschuh

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7590826

30 May 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7590826

30 May 2024

publication date

1 June 1995

1 reference

full work available at URL

20 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1600-065X.1995.tb00082.x

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1600-065X.1995.tb00082.x

30 May 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

30 May 2024

published in

Immunological Reviews

1 reference

20 September 2017

volume

145

1 reference

20 September 2017

page(s)

179-209

1 reference

Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

T-cell based cancer immunotherapy: direct or redirected tumor-cell recognition?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

A severe combined immunodeficiency mutation in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

Evidence of functional lymphocytes in some (leaky) scid mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

Characterisation of a humanised bispecific monoclonal antibody for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

Costimulation of T cells for tumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

Cytotoxicity mediated by human Fc receptors for IgG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

Human T cell activation. II. A new activation pathway used by a major T cell population via a disulfide-bonded dimer of a 44 kilodalton polypeptide (9.3 antigen)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

The PI-linked receptor FcRIII is released on stimulation of neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

Lysis of ovarian cancer cells by human lymphocytes redirected with a chimeric gene composed of an antibody variable region and the Fc receptor gamma chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

The B7 and CD28 receptor families

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

Role of the CD28 receptor in T-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

Recent efforts to establish an in vivo model as a new experimental tool in the study of Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

Production of target-specific effector cells using hetero-cross-linked aggregates containing anti-target cell and anti-Fc gamma receptor antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

Debate: the mechanism of lymphocyte-mediated killing. Perforin-induced pore formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

Local antitumour treatment in carcinoma patients with bispecific-monoclonal-antibody-redirected T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

Structure and function of human perforin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

Costimulation of T-cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

Interleukin-2 in cancer treatment: disappointing or (still) promising? A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

The origin and function of tumor-associated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

Antitumor activity of recombinant interleukin 6 in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

Susceptibility to cytotoxic T lymphocyte-induced apoptosis is a function of the proliferative status of the target

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

Preliminary trial of specific targeting therapy against malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

Immune interferon induces the receptor for monomeric IgG1 on human monocytic and myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

Activation of natural killer cells via the p75 interleukin 2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

Effect of polymorphism of an MHC-linked transporter on the peptides assembled in a class I molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

Identification of human cancers deficient in antigen processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

Modulation of T-cell function by gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

Two-step TCR zeta/CD3-CD4 and CD28 signaling in T cells: SH2/SH3 domains, protein-tyrosine and lipid kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

21 January 2018

T-cell clonal anergy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

The major Fc receptor in blood has a phosphatidylinositol anchor and is deficient in paroxysmal nocturnal haemoglobinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

A natural killer cell granule protein that induces DNA fragmentation and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

Homology of perforin to the ninth component of complement (C9).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

Targeted toxins as anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

Adhesion receptors of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

Structure and function of human and murine receptors for IgG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

Signal transduction by lymphocyte antigen receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

Specific targeting of cytotoxic T cells by anti-T3 linked to anti-target cell antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

Targeted cytotoxic cells as a novel form of cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

Activation and expansion of tumour-infiltrating lymphocytes by anti-CD3 and anti-CD28 monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

An alternative pathway of T-cell activation: A functional role for the 50 kd T11 sheep erythrocyte receptor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

Hybrid hybridomas and their use in immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00082.X

Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules

21 January 2018

4

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

Human T cell activation: differential response to anti-CD28 as compared to anti-CD3 monoclonal antibodies.

30 May 2024

7

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

30 May 2024

12

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

Production of IL-10 by melanoma cells: examination of its role in immunosuppression mediated by melanoma

30 May 2024

15

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

Genes coding for tumor antigens recognized by human cytolytic T lymphocytes

30 May 2024

19

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

The cell of origin in Hodgkin's disease

30 May 2024

24

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

Localization of monoclonal antibody G250 and bispecific monoclonal antibody CD3/G250 in human renal-cell carcinoma xenografts: Relative effects of size and affinity

30 May 2024

25

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

Perspectives on the role of MHC antigens in normal and malignant cell development

30 May 2024

29

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

Antitumor effects of ricin A chain immunotoxins prepared from intact antibodies and Fab' fragments on solid human Hodgkin's disease tumors in mice

30 May 2024

30

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

Targeting of T or NK lymphocytes against tumor cells by bispecific monoclonal antibodies: role of different triggering molecules

30 May 2024

34

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

The LFA-1/ICAM cell adhesion pathway is involved in tumor-cell lysis mediated by bispecific monoclonal-antibody-targeted T lymphocytes

30 May 2024

36

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

Immune surveillance: both CD3+ CD4+ and CD3+ CD8+ T cells control in vivo growth of P815 mastocytoma.

30 May 2024

37

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

Efficient expansion of tumor-infiltrating lymphocytes from solid tumors by stimulation with combined CD3 and CD28 monoclonal antibodies

30 May 2024

38

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

Regulation of T-cell lymphokine gene transcription by the accessory molecule CD28

30 May 2024

40

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

Selective induction of B7/BB-1 on interferon-γ stimulated monocytes: A potential mechanism for amplification of T cell activation through the CD28 pathway

30 May 2024

41

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice

30 May 2024

42

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

Adoptive T Cell Therapy of Tumors: Mechanisms Operative in the Recognition and Elimination of Tumor Cells

30 May 2024

45

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

Mice expressing both B7-1 and viral glycoprotein on pancreatic beta cells along with glycoprotein-specific transgenic T cells develop diabetes due to a breakdown of T-lymphocyte unresponsiveness

30 May 2024

50

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

Target-cell sensitivity to natural killer-cell lysis is determined by the expression of a novel antigen in conjunction with major histocompatibility complex class-I molecules

30 May 2024

51

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

Tumor immunology: an overview

30 May 2024

52

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gamma

30 May 2024

54

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

"Diabodies": small bivalent and bispecific antibody fragments

30 May 2024

55

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

A CD16/CD30 bispecific monoclonal antibody induces lysis of Hodgkin's cells by unstimulated natural killer cells in vitro and in vivo

30 May 2024

56

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

Interleukin-4 plus tumor necrosis factor alpha augments the antigenicity of melanoma cells

30 May 2024

57

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

Targeting HIV-1 to Fc gamma R on human phagocytes via bispecific antibodies reduces infectivity of HIV-1 to T cells

30 May 2024

58

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

The genetic modification of T cells for cancer therapy: an overview of laboratory and clinical trials

30 May 2024

61

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

Induction of cytotoxicity in resting human T lymphocytes bound to tumor cells by antibody heteroconjugates

30 May 2024

65

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

Transactivation by AP-1 is a molecular target of T cell clonal anergy

30 May 2024

67

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

Expansion of tumor-infiltrating lymphocytes from human tumors using the T-cell growth factors interleukin-2 and interleukin-4

30 May 2024

70

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

Effectors, repertoire and receptors involved in lymphocyte-mediated mhc-unrestricted cytotoxicity

30 May 2024

76

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg

30 May 2024

77

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway

30 May 2024

80

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

The role of the CD28 receptor during T cell responses to antigen

30 May 2024

82

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

The development of biological therapies for breast cancer

30 May 2024

83

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

Induction of synthesis of the cytolytic C9 (ninth component of complement)-related protein in human peripheral mononuclear cells by monoclonal antibody OKT3 or interleukin 2: correlation with cytotoxicity and lymphocyte phenotype

30 May 2024

87

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

Tumor eradication by adoptive transfer of cytotoxic T lymphocytes

30 May 2024

89

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

The epidermal growth factor receptor as a target for therapy with antireceptor monoclonal antibodies

30 May 2024

90

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

Bispecific-monoclonal-antibody-directed lysis of ovarian carcinoma cells by activated human T lymphocytes

30 May 2024

95

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

Transport protein genes in the murine MHC: possible implications for antigen processing

30 May 2024

96

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

Surface molecules involved in the activation and regulation of T or natural killer lymphocytes in humans

30 May 2024

98

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

Selective in Vitro Growth of T Lymphocytes from Normal Human Bone Marrows

30 May 2024

99

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

Redirected targeting of LDL to human monocyte Fc gamma receptors with bispecific antibodies

30 May 2024

100

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

30 May 2024

Cancer vaccines

109

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

CD30-antigen-specific targeting and activation of T cells via murine bispecific monoclonal antibodies against CD3 and CD28: potential use for the treatment of Hodgkin's lymphoma

30 May 2024

114

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

Activation of mononuclear cells to be used for hybrid monoclonal antibody-induced lysis of human ovarian carcinoma cells

30 May 2024

116

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

Karnofsky Memorial Lecture. The immunotherapy and gene therapy of cancer

30 May 2024

124

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

Remote T cell co-stimulation via LFA-1/ICAM-1 and CD2/LFA-3: Demonstration with immobilized ligand/mAb and implication in monocyte-mediated co-stimulation

30 May 2024

135

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

30 May 2024

140

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

Hybrid hybridoma producing a bispecific monoclonal antibody that can focus effector T-cell activity

30 May 2024

142

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines

30 May 2024

144

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells

30 May 2024

146

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

Perforin-mediated target cell lysis by cytolytic T lymphocytes

30 May 2024

147

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

Requirements for activation of human peripheral blood T cells by mouse monoclonal antibodies to CD3

30 May 2024

148

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

Role of Fc gamma receptors in cancer and infectious disease.

30 May 2024

151

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

Immune function in mice lacking the perforin gene

30 May 2024

152

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

Killing of target cells by lymphocytes: a mechanistic view

30 May 2024

156

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00082.X

30 May 2024

Identifiers

1 reference

20 September 2017

1 reference